Form 4: Herbalife Executive Stephan Paulo Gratziani Reports Acquisition of Stock Appreciation Rights

Sentiment:

SEC Form 4 Filing


Herbalife President Stephan Paulo Gratziani reports the acquisition of stock appreciation rights (SARs) in a recent SEC filing.

Summary

  • Stephan Paulo Gratziani, President of Herbalife Ltd., filed a Form 4 with the SEC.
  • The filing reports the acquisition of 309,734 stock appreciation rights (SARs) on February 21, 2025, at a price of $8.31.
  • These SARs were granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan.
  • The SARs will vest in one-third increments on February 21, 2026, February 21, 2027, and February 21, 2028, contingent upon continued service.
  • Following the transaction, Gratziani directly owns 309,734 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing related to executive compensation. The grant of SARs is generally viewed as a positive incentive, but it doesn't necessarily indicate a significant shift in the company's prospects.

Positives

  • The grant of SARs to a key executive like the President can be seen as an incentive to align their interests with the long-term performance of the company.
  • The vesting schedule encourages continued service and commitment from the executive.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's future performance, but the vesting schedule of the SARs suggests an expectation of continued service from the executive.

Industry Context

The granting of stock appreciation rights is a common practice in corporate compensation to incentivize executives and align their interests with shareholder value. This is a standard method used by companies like Herbalife to retain and motivate key personnel.

Comparison to Industry Standards

  • Companies like Nu Skin Enterprises and USANA Health Sciences also utilize stock-based compensation, including stock options and restricted stock units, to incentivize their executives.
  • The vesting schedules and terms of these grants are typically aligned with industry benchmarks to attract and retain talent.
  • The specific terms of Herbalife's SARs, such as the vesting schedule and exercise price, would need to be compared to those of similar companies to assess their competitiveness.

Stakeholder Impact

  • Shareholders may view the grant of SARs as a positive sign, aligning executive interests with company performance.
  • Employees may see this as a positive sign of investment in leadership.

Key Dates

DateDescription
02/21/2025Date of transaction: Grant of stock appreciation rights (SARs).
02/21/2026First vesting date for one-third of the SARs.
02/21/2027Second vesting date for one-third of the SARs.
02/21/2028Final vesting date for one-third of the SARs.
02/21/2035Expiration date of the SARs.
02/25/2025Date of filing of the SEC Form 4.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.